Yesterday, the FDA voted to approve flibanserin, a new drug to treat women with hypoactive sexual desire disorder, or lack of desire for sex. The drug, marketed as Addyi, has been touted as “female Viagra,” in the sense that it helps bring sex back into these women’s lives. But flibanserin doesn’t actually work like…
An FDA advisory committee voted to recommend approval of flibanserin, which would become the first drug to treat low libido in women (in anyone, for that matter—Viagra treats erectile dysfunction, not libido).
The makers of a female Viagra-type pill are re-submitting their application to the Food and Drug Administration, though it's already been rejected twice. If approved, Sprout Pharmaceuticals' pill would be the first of its kind for women with libido issues.